Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2

Full article: Chemokine receptor antagonists: Part 1

Chemokines and Chemokine Receptors - Creative Diagnostics

Structural Analysis of Chemokine Receptor–Ligand Interactions

CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC

Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect

A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation

Immune regulation by atypical chemokine receptors

Structural Analysis of Chemokine Receptor-Ligand Interactions. - Abstract - Europe PMC

CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC

Cobalt-Catalyzed C–H Activation

Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration - ScienceDirect

Full article: Future therapeutic treatment of COPD: Struggle between oxidants and cytokines

Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist

The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities